Agonists are mainly AVP analogs that bind to the same receptor site (orthosteric) as natural AVP, which are used to bolster AVP signaling in loss-of-function conditions, e.g., diabetes insipidus and septic shock ([302], reviewed in [303]). The gene discussed is AVP; the disease is Central diabetes insipidus.